Table 9.
Pathogen | Vaccine Tradename | Route of Administration | Adjuvant | Manufacturer |
---|---|---|---|---|
SARS-CoV-2 (COVID-19) Vaccine * | COMIRNATY® | Intramuscular | LNP | Pfizer Inc. New York, USA/BioNTech SE.Mainz Germany |
SARS-CoV-2 (COVID-19) Vaccine ** | SpikeVax® | Intramuscular | LNP | ModernaTx, Inc. Massachusetts, USA |
* Comirnaty was granted additional approval for the use in 5–16 years old. ** Authorized for emergency use as of publication date.